These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20434014)

  • 1. Membrane microvesicles: macromessengers in cancer disease and progression.
    Castellana D; Toti F; Freyssinet JM
    Thromb Res; 2010 Apr; 125 Suppl 2():S84-8. PubMed ID: 20434014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression.
    Castellana D; Kunzelmann C; Freyssinet JM
    Hamostaseologie; 2009 Jan; 29(1):51-7. PubMed ID: 19151847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microparticles, thrombosis and cancer.
    Aharon A; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):61-9. PubMed ID: 19285273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane microparticles in VTE and cancer.
    Key NS; Chantrathammachart P; Moody PW; Chang JY
    Thromb Res; 2010 Apr; 125 Suppl 2():S80-3. PubMed ID: 20434013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticles in cancer.
    Rak J
    Semin Thromb Hemost; 2010 Nov; 36(8):888-906. PubMed ID: 21049390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of procoagulant microparticles and properties.
    Freyssinet JM; Toti F
    Thromb Res; 2010 Apr; 125 Suppl 1():S46-8. PubMed ID: 20153515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvesicles as risk markers for venous thrombosis.
    Rautou PE; Mackman N
    Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumour-derived microvesicles in plasma of gastric cancer patients.
    Baran J; Baj-Krzyworzeka M; Weglarczyk K; Szatanek R; Zembala M; Barbasz J; Czupryna A; Szczepanik A; Zembala M
    Cancer Immunol Immunother; 2010 Jun; 59(6):841-50. PubMed ID: 20043223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticles and thrombotic disease.
    Davizon P; López JA
    Curr Opin Hematol; 2009 Sep; 16(5):334-41. PubMed ID: 19606028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of platelet-derived microparticles in tumor progression and thrombosis.
    Mezouar S; Mege D; Darbousset R; Farge D; Debourdeau P; Dignat-George F; Panicot-Dubois L; Dubois C
    Semin Oncol; 2014 Jun; 41(3):346-58. PubMed ID: 25023350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
    Rak J; Klement P; Yu J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new look at platelets and microparticles, including their role in haemostatic disorders and progression of neoplastic disease].
    Łuksza E; Mantur M
    Pol Merkur Lekarski; 2009 Dec; 27(162):491-5. PubMed ID: 20120715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of cell membrane microparticles.
    Gelderman MP; Simak J
    Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procoagulant microparticles: disrupting the vascular homeostasis equation?
    Morel O; Toti F; Hugel B; Bakouboula B; Camoin-Jau L; Dignat-George F; Freyssinet JM
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2594-604. PubMed ID: 16990554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated thrombosis.
    Furie B; Furie BC
    Blood Cells Mol Dis; 2006; 36(2):177-81. PubMed ID: 16490369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
    Muhsin-Sharafaldine MR; Saunderson SC; Dunn AC; Faed JM; Kleffmann T; McLellan AD
    Oncotarget; 2016 Aug; 7(35):56279-56294. PubMed ID: 27462921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication.
    Ratajczak J; Wysoczynski M; Hayek F; Janowska-Wieczorek A; Ratajczak MZ
    Leukemia; 2006 Sep; 20(9):1487-95. PubMed ID: 16791265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
    Falanga A; Marchetti M; Vignoli A; Balducci D
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microparticles, lupus anticoagulant and recurrent miscarriages.
    Alijotas-Reig J; Palacio-Garcia C; Vilardell-Tarres M
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):22-6. PubMed ID: 19410360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.